BioSpace News Archive

Zimmer Biomet Holdings, Inc. announced its fourth quarter earnings conference call will be webcast on Monday, February 7, 2022 at 8:30 a.m. ET.

ZIVO Bioscience, Inc., a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces that Chairman of the Board John B. Payne has been named President and Chief Executive Officer of the Company.

The global radiometric detectors market is expected to offer a comprehensive analysis of the respective market shares of leading market players, key strategies, and business models pertaining to the existing landscape.

The study is a double-blind, placebo-controlled, exploratory randomized clinical trial to assess the safety and efficacy of IFB-088 plus riluzole 100 mg, vs placebo plus riluzole 100 mg in patients with bulbar-onset ALS.

We are all delighted to welcome Ms. Damiano to our diverse team of highly motivated industry experts.

According to Emergen Research, the global dermal regeneration template market size was USD 722.1 Million in 2020 and is expected to reach USD 1,581.9 Million in 2028 and register a revenue CAGR of 10.2% during the forecast period, 2021-2028.

Sarepta Therapeutics, Inc. today announced topline results from Part 2 of Study SRP-9001-102 (Study 102), an ongoing, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety, efficacy and tolerability of a single dose of SRP-9001.

According to Emergen Research, the global industrial microbiology market size was USD 11.53 billion in 2020 and is expected to reach USD 18.9 billion in 2028 and register a revenue CAGR of 6.8% during the forecast period, 2021-2028.

According to Emergen Research, the global medical device testing services market size was USD 7.88 billion in 2020 and is expected to reach USD 15.60 billion in 2028 and register a revenue CAGR of 9.5% during the forecast period, 2021-2028.

According to Emergen Research, the global prenatal testing market size was USD 3.64 billion in 2020 and is expected to reach USD 9.12 billion in 2028 and register a revenue CAGR of 12.9% during the forecast period, 2021-2028.